Department of Molecular Immunology, Institute of Industrial Science, The University of Tokyo, Tokyo 153-8505, Japan.
Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan.
Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):10178-10183. doi: 10.1073/pnas.1712837114. Epub 2017 Sep 6.
The commensal microbiota within the gastrointestinal tract is essential in maintaining homeostasis. Indeed, dysregulation in the repertoire of microbiota can result in the development of intestinal immune-inflammatory diseases. Further, this immune regulation by gut microbiota is important systemically, impacting health and disease of organ systems beyond the local environment of the gut. What has not been explored is how distant organs might in turn shape the microbiota via microbe-targeted molecules. Here, we provide evidence that surfactant protein D (SP-D) synthesized in the gallbladder and delivered into intestinal lumen binds selectively to species of gut commensal bacteria. SP-D-deficient mice manifest intestinal dysbiosis and show a susceptibility to dextran sulfate sodium-induced colitis. Further, fecal transfer from SP-D-deficient mice to wild-type, germ-free mice conveyed colitis susceptibility. Interestingly, colitis caused a notable increase in gene expression in the gallbladder, but not in the lung, via the activity of glucocorticoids produced in the liver. These findings describe a unique mechanism of interorgan regulation of intestinal immune homeostasis by SP-D with potential clinical implications such as cholecystectomy.
肠道内的共生微生物菌群对于维持体内平衡至关重要。事实上,微生物菌群的组成失调可能导致肠道免疫炎症性疾病的发生。此外,肠道微生物菌群的这种免疫调节作用具有重要的系统性影响,会影响到肠道以外的其他器官系统的健康和疾病。目前尚未探索的是,远处的器官如何通过针对微生物的分子反过来塑造微生物菌群。在这里,我们提供的证据表明,在胆囊中合成并输送到肠道腔中的表面活性剂蛋白 D(SP-D)选择性地与肠道共生细菌的物种结合。SP-D 缺陷型小鼠表现出肠道菌群失调,并易患葡聚糖硫酸钠诱导的结肠炎。此外,从 SP-D 缺陷型小鼠到无菌野生型小鼠的粪便转移传递了结肠炎易感性。有趣的是,结肠炎通过肝脏产生的糖皮质激素的活性,导致胆囊而非肺部的 基因表达显著增加。这些发现描述了 SP-D 介导的肠免疫稳态的器官间调节的独特机制,具有潜在的临床意义,例如胆囊切除术。